Superior mesenteric vein thrombosis – unusual management of unusual complication of Whipple procedure  by Huťan, Martin et al.
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INTRODUCTION:  Pancreatoduodenectomy  is an  extensive  procedure  carrying  risk of  a number  of  post-
operative  complications.  Of these  the  most common  are  surgical  site  infections  (SSI),  bleeding,  delayed
gastric  emptying,  and  anastomotic  leakage.  However,  the  most  serious  complications  are  ones,  that  are
rare, clinically  hardly  diagnosed,  and  if untreated,  leading  to the  death  of a patient.  Among  the  latter
complications  is  thrombosis  of superior  mesenteric  vein.  Its  clinical  signs  are  unspeciﬁc  and  diagnostics
complicated.  Treatment  requires  aggressive  approach.  If this  is  absent,  intestinal  necrosis  with  septic
state,  Multiple  Organ  Dysfunction  Syndrome  (MODS)  and  Multiple  Organ  Failure  (MOF)  lead  to a  death
of a patient.
PRESENTATION  OF  CASE:  Authors  present  a case  of  a patient  after pancreatoduodenectomy,  complicated
by  the  thrombosis  of  superior  mesenteric  vein.  Patient  was  managed  by resection  of the  necrotic  bowel,
venous  decompression  by venous  bypass  from  superior  mesenteric  vein  to the  right  ovarian  vein, and
open  abdomen  with  negative  pressure  wound  therapy  (NPWT).  Patient  suffered  severe  abdominal  sepsis
with need  for intensive  organ  support.  Abdomen  was  deﬁnitely  closed  on fourth  NPWT  redress.  Patient
healed  without  any  further  complications,  is  well  and  was  released  to  the  ambulatory  setting.
DISCUSSION:  Superior  mesenteric  vein  (VMS)  thrombosis  is a  rare complication.  It  diagnosis  requires  high
level of vigilance  and  once  diagnosed,  aggressive  therapy  is essential.  Two  goals  of surgical  treatment
exist:  resection  of  the  necrotic  bowel  and facilitation  of the  blood  outﬂow.
CONCLUSION:  Mesenteroovarian  anastomosis  is  one  of  the options  in  treatment  of  thrombosis  of  VMS  if
thrombectomy  is  not  feasible.
© 2014  The  Authors.  Published  by Elsevier  Ltd.  on behalf  of  Surgical  Associates  Ltd.  This  is  an  open
he  CCaccess  article  under  t
. Introduction
Pancreatoduodenectomy is primarily indicated in two  cases:
umor of periampullary area (carcinoma of the head of the pan-
reas, ampulla of Vater, distal common bile duct, and duodenum)
r chronic pancreatitis with pathological changes in the head
f the pancreas or the uncinate process of the pancreas. Tak-
ng into account the extent of the procedure (mobilization of the
Abbreviations: CRP, C-reactive protein; CT, Computer Tomography; ERCP, Endo-
copic Retrograde Cholangiopancreaticography; IPP, Proton Pump Inhibitor; IU,
nternational Units; LMWH,  Low molecular weight heparin; MODS, Multiple Organ
ysfunction Syndrome; MOF, Multiple Organ Failure; NPWT, Negative Pressure
ound Therapy; PCT, Procalcitonine; SSI, Surgical Site Infection; SMV, Superior
esenteric vein; UFH, Unfractioned heparin; WBC, White blood cell count.
∗ Corresponding author at: IInd Surgical Department of Medical Faculty, Comen-
us  University, University Hospital Bratislava, Hospital of St. Cyril and Methodius,
ntolská 11, 85107 Bratislava, Slovakia. Tel.: +421 2 68673328.
E-mail address: matohuto@yahoo.com (M.  Hut’an).
ttp://dx.doi.org/10.1016/j.ijscr.2014.09.004
210-2612/© 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical A
http://creativecommons.org/licenses/by-nc-nd/3.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
duodenum, dissection and manipulation in the area of superior
mesenteric vessels and the portal vein, dissection of hepatoduo-
denal ligamentum with transection of the common bile duct,
resection of the distal stomach, resection of the head of the pan-
creas, and construction of anastomoses on the common bile duct
and the pancreatic duct) and the state of the patient with underly-
ing diseases (malnutrition, cardiovascular and metabolic diseases),
the risk of serious complications is elevated.
Most common complications of pancreatoduodenectomy can
be divided in four groups: SSI, delayed gastric emptying, bleed-
ing, and anastomotic leakage.1 Nevertheless, other complications,
much less frequent, exist. Their identiﬁcation in early postopera-
tive course is complicated and if left untreated, leading to the death
of a patient.
Among such complications is superior mesenteric vein (SMV)
thrombosis with subsequent ischemia of the tributary area. Clin-
ical symptoms of SMV  thrombosis are untypical, obscure and
characterized by slow progress, all this covered by early postop-
erative period.2 Because of these obscure symptoms, it was not
ssociates Ltd. This is an open access article under the CC BY-NC-ND license
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Picture 1. CT on third postoperative day showing venostatic jejunum with thick-
ened intestinal wall.CASE  REPORT
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ntil 1935, that thrombosis of SMV  was identiﬁed as a nosol-
gy entity.3,4 This complication was described in the literature
ot only after pancreatoduodenectomy,5 but also after surgery for
nﬂammative bowel disease,6 fundoplication,7 acute appendicitis,8
nd splenectomy.9 All papers are case ﬁles describing this rare
omplication.
Therapy of thrombosis of SMV  is divided into conservative,
ndovascular, and surgical treatment. Basis of the conservative
reatment was stated by the classical paper by Barrit and Jor-
an in 1960. In this work authors present acute heparinization
f the patient as a fundamental therapy of thromboembolic
omplications.10 Treatment of the thrombosis of SMV  does not
iffer from the treatment of the thrombosis in any other local-
zation. Initial treatment goal is cessation of thrombotisation
nd enabling of body’s ﬁbrinolytic activity for destruction of the
hrombus. Administration of the therapeutic dosage of heparin
rovides immediate effect. Another possibility is thrombolysis,
ither administered systemically or locally. One of the possibilities
escribed in the literature is transfemoral introduction and appli-
ation of alteplase in superior mesenteric artery (SMA).11 Another
nteresting possibility described in the literature is direct aspiration
hrombectomy from SMV  without use of thrombolysis.12 Surgical
herapy is indicated on the basis of clinical state and has two  goals.
irst goal is facilitation of venous outﬂow (usually by thrombec-
omy) and second one is assessment of the vitality of the bowel
ith resection of necrotic segments. In contrast to arterial ischemia,
he border between ischemic and livid bowel is less visible and
dentiﬁable, and second look laparotomy is indicated if in doubt.13
Prognosis of the patient depends on the clinical state, early iden-
iﬁcation of this complication, and aggressive treatment. Mortality
f the patients with necrotic bowel, after extensive operation, and
ith developed abdominal sepsis is high; the treatment is multidis-
iplinary (surgeon, anesthesiologist, internal medicine specialist,
adiologist, clinical microbiologist, and gastroenterologist), com-
licated, timely and ﬁnancially demanding.
. Case ﬁle
A 38-year-old female patient, with cystic tumor in the head
f the pancreas, with compression of the common bile duct and
ancreatic duct, after unsuccessful ERCP (endoluminal cholan-
iopancreaticography), with persistent pain, was admitted to our
epartment for elective operation. Patient’s history had heroin
buse, syphilis, chronic pancreatitis; currently the patient free from
rugs for the past eight years. Patient had no hematologic dis-
ases or disorders. During the operation, we encountered difﬁcult
reparation of the head of the pancreas, which was in a ﬁbrotic
errain. Cystic formation with pancreaticolits was present in the
ead of the pancreas, without connection to Wirsung duct. Cephalic
ancreatoduodenectomy was performed, with reconstruction by
ancreatojejunoanastomosis, then choledochojejunoanastomosis
nd gastrojejunoanastomosis on one intestinal loop. Preopera-
ively medical treatment included prophylactic antibiotics (1st
eneration cephalosporins), later changed to therapeutic antibi-
tics (carbapenems), postoperative therapy included prophylactic
osage of LMWH  (Fraxiparine 0.3 ml  s.c. 1 d, Glaxo Group LTD,
reat Britain), PPI (proton pump inhibitor), analgesia, all-in-one
utrition.
High production in Tygon drains was present in early postop-
rative period (1200 ml,  800 ml,  and 700 ml,  respectively). No signs
f elevated levels of bilirubin or amylases were found in exudate
rom the drains. Clinically, the abdomen was without peritoneal
igns, audibly with weak but present peristaltic movements. On the
hird postoperative day, we performed CT with per oral and intra-
enous administration of contrast, without ﬁnding leakage from
he hollow tube of gastrointestinal tract, without free ﬂuid in thePicture 2. Perioperative ﬁnding of ischemic and necrotic bowel during surgical
revision on fourth postoperative day.
abdominal cavity, without signs of thrombosis of SMV, portal vein
or splenic vein. Edematous efferent loop of jejunum was the dom-
inating ﬁnding on the CT, with intestinal wall being thickened to
20 mm (Picture 1). On the fourth postoperative day, while consider-
ing worsening clinical state, elevation of inﬂammatory parameters
(WBC, CRP, PCT – white blood cell count, C-reactive protein, pro-
calcitonine) and suspicion for venous ischemia of the bowel we
indicated the patient for surgical revision.
During the surgery, we found severe venous congestion of the
small intestine and caecum, with ischemic and necrotic areas on
distal ileum (Picture 2). The cause of this congestion was palpable
thrombosis of SMV  passing on to portal vein. Vascular surgeon was
called to the operation theater and decision was made for venous
derivation of SMV  by means of mesentericocaval bypass. Based on
local anatomical conditions, bypass was  performed between the
most proximal branch of SMV  and the right ovarian vein, with end-
to-end anastomosis (Picture 3). Because of the necrotic areas on the
bowel the resection of the distal ileum (approximately 40–50 cm)
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bicture 3. Constructed anastomosis between proximal branch of SMV  and right
varian vein.
nd caecum was performed, and the terminal ileostomy was con-
tructed, patient was left with the open abdomen with NPWT –
egative pressure wound therapy (Vivanomed, Paul Hartmann AG,
ermany) (Picture 4). During the operation the treatment with
FH 3 × 5000 IU was initiated, LMWH  was discontinued. Postop-
ratively the patient required intensive organ support in terms of
rtiﬁcial ventilation, vasopressor and diuretic support, and antibi-
tic therapy. On sixth day, ninth day, and eleventh day, the redress
f the open abdomen was done, on the last day the suture of the
bdominal wall was performed. No additional bowel needed to
e resected, venostasis of the bowel diminished. Patient resolved
rom abdominal sepsis without further complications. After resum-
ng the oral intake, without the need for further intervention, the
atient was on 24th postoperative day after primary operation
eleased from the hospital. Further anticoagulant therapy will be
irected by hematologist in out-patient setting.
Deﬁnite histological ﬁnding was chronic pancreatitis, without
igns of malignancy.
. Discussion
Identiﬁcation of the thrombosis of SMV  in early postoperative
ourse is complicated by fact that clinical symptoms are non-
peciﬁc and covered by postoperative paralysis of gastrointestinal
ract and modiﬁed pain reaction by the administration of the
nalgetics. Currently, no plasma biomarkers speciﬁc for intestinal
schemia exist. Use of D dimer as a marker of ﬁbrinolysis has high
ensitivity, but low speciﬁcity,14 and can be used for exclusion of
iagnosis at best. Imaging techniques might show secondary con-
equences of thrombosis, but will not rule out thrombosis itself.
If suspicion for thrombosis of SMV  is raised, together with clin-
cal deterioration of the patient, with present signs of peritoneal
ounding, or bowel paralysis of unclear origin, laparotomy revisionPicture 4. Open abdomen with intraabdominal NPWT applied.
should be considered. Goal of laparotomy is exclusion or afﬁrma-
tion of thrombosis, facilitation of venous drainage, and resection of
the necrotic parts of the bowel. Considering complicated assess-
ment of the bowel vitality in venous congestion, recommended
practice is planned relaparotomy 24–48 h after revision.
Mechanical injury to VSM can be considered as the most com-
mon  cause of postoperative thrombosis of SMV. This is especially
true in patients, where the pancreas and its surroundings are
changed by chronic pancreatitis to ﬁbrotic, hard-to-dissect tissue.
It is difﬁcult to state, though, where the thrombosis did originate
in our patient, since by lowering of blood ﬂow the thrombosis pro-
gressed to palpable thrombosis of the main trunk of the superior
mesenteric vein passing on to portal vein. Interesting is the extent
of thrombosis in this patient, that had no systemic hematologic
disorders.
Management of the patient is multidisciplinary, usually requir-
ing intensive organ support guided by anesthesiologist or surgeon
with interest in intensive therapy. Anticoagulation therapy with
heparin should be initiated, either by continuous or bolus adminis-
tration of UFH. Experiences with use of LMWH  in this indication are
absent, but no logical reason exist, that LMWH  would be inferior in
efﬁciency.15
Management of patient in-between surgical revisions by use of
open abdomen with NPWT has substantial advantages over using
temporary abdominal coverage without use of negative pressure.
Its advantage is elimination of possible compartment syndrome as
well as direct local therapy and evacuation of septic burden.164. Conclusion
Pancreatoduodenectomy is an extensive surgical procedure,
which has speciﬁcally given indications. Possible complications of
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his procedure are grave and may  lead to the death of a patient.
he most dangerous complications are ones, which have vague,
on-speciﬁc symptoms. Among these complications is thrombo-
is of SMV  that, although rare, if left untreated leads to abdominal
epsis and death of a patient. Diagnostics has to be brisk and ther-
py aggressive, treatment being multidisciplinary under the lead
f a surgeon. Mesenteroovarian anastomosis is one of the options
n treatment of thrombosis of VMS  if thrombectomy is not feasi-
le. Use of open abdomen with use of NPWT should be a part of a
anagement of planned relaparotomy.
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